Erythropoietin exerts cell protective effect by activating PI3K/Akt and MAPK pathways in C6 Cells

Even though erythropoietin (EPO) is a neurotropic cytokine that is recognized widely for its role in the development, maintenance, protection, and repair of the nervous system, there are few reports concerning EPO-mediated influences on the glial cells in the central nervous system. In this study, w...

Full description

Saved in:
Bibliographic Details
Published in:Neurological research (New York) 2014-03, Vol.36 (3), p.215-223
Main Authors: Kwon, Min-Soo, Kim, Mi-Hee, Kim, Seon-Hee, Park, Ki-Dae, Yoo, Si-Hyung, Oh, Il-Ung, Pak, Suenie, Seo, Young-Jun
Format: Article
Language:English
Subjects:
Animals
Anti-inflammation
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
C6 cells
Cell Line, Tumor
Cell protection
Cell Survival
Erythropoietin
Erythropoietin - metabolism
Erythropoietin - pharmacology
Inflammation Mediators - metabolism
MAP Kinase Signaling System - drug effects
Neuroglia - drug effects
Neuroglia - metabolism
Neuroprotective Agents - pharmacology
Phosphatidylinositol 3-Kinase - metabolism
Proto-Oncogene Proteins c-akt - metabolism
Rats
Signal pathway
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Even though erythropoietin (EPO) is a neurotropic cytokine that is recognized widely for its role in the development, maintenance, protection, and repair of the nervous system, there are few reports concerning EPO-mediated influences on the glial cells in the central nervous system. In this study, we investigated anti-inflammatory and anti-apoptotic effects of EPO on C6 glioma cells (C6 cells). Erythropoietin did not attenuate inflammatory response, such as nitrite production, iNOS gene expression, and pro-inflammatory cytokines when LPS/TNF-alpha mixture was treated. However, EPO increased C6 cell viability by exerting cell protective effect against staurosporine stimulation. Erythropoietin increased the transient Akt expression at 30 minutes and induced the gradual elevation of ERK1/2 and p38 expression as time progressed. The cell protective effect of EPO was also significantly attenuated with pretreatment of specific PI3K, pERK1/2, or pP38 inhibitor. In summary, these results suggest that EPO may exert its cell protective functions via the direct cell protective activity rather than via its anti-inflammatory effect. Moreover, the PI3K/Akt and mitogen activated protein kinase (MAPK) pathways may be responsible for cell survival against cytotoxicity.
ISSN:0161-6412
1743-1328
DOI:10.1179/1743132813Y.0000000284